|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
DEXAMETHASONE SODIUM PHOSPHATE AND NEOMYCIN SULFATE
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Dermatitis, atopic |
|
Dermatitis, contact |
|
Dermatitis, exfoliative |
|
Dermatitis, seborrheic |
| |
|
|
SIDE EFFECTS:
|
|
Bacterial keratitis |
|
burning or stinging of the ear |
|
Cushing's syndrome |
|
dermatological changes |
|
diabetes mellitus |
|
endocrine disturbances |
|
fluid or electrolyte disturbances |
|
gastrointestinal changes |
|
hypokalemic syndrome |
|
musculoskeletal changes |
|
neurological changes |
|
persistent fungal infections of the ear |
|
muscle wasting |
|
thromboembolism |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Congestive heart failure |
|
Diabetes mellitus |
|
Epilepsy |
|
Glaucoma |
|
Hypertension |
|
Infections, ear, acute |
|
Infections, ear, chronic |
|
Otitis media, especially in children |
|
Osteoporosis |
|
|
ADULT DOSE:
|
|
Topical, to the ear canal, 3 or 4 drops of a 0.1% (phosphate) solution two or three times a day. After a favorable response is obtained, dosage may be gradually reduced if required to provide continuing control of symptoms prior to discontinuation.
|
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Topical, to the ear canal, 3 or 4 drops of a 0.1% (phosphate) solution two or three times a day. After a favorable response is obtained, dosage may be gradually reduced if required to provide continuing control of symptoms prior to discontinuation.
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
Topical, to the ear canal, 3 or 4 drops of a 0.1% (phosphate) solution two or three times a day. After a favorable response is obtained, dosage may be gradually reduced if required to provide continuing control of symptoms prior to discontinuation.
|
|
|
|
|